9B8G image
Deposition Date 2024-03-29
Release Date 2024-11-06
Last Version Date 2025-10-15
Entry Detail
PDB ID:
9B8G
Keywords:
Title:
2C9 Fab antibody fragment against the E protein of the Yellow Fever virus
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.66 Å
R-Value Free:
0.25
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:2C9 Fab heavy chain
Chain IDs:A, C, E (auth: H)
Chain Length:230
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:2C9 Fab light chain
Chain IDs:B, D, F (auth: L)
Chain Length:218
Number of Molecules:3
Biological Source:Homo sapiens
Primary Citation
A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity.
Nat Commun 16 8449 8449 (2025)
PMID: 41006244 DOI: 10.1038/s41467-025-63038-5

Abstact

Yellow fever virus (YFV) is a re-emerging flavivirus that causes severe hepatic disease and mortality in humans. Despite being researched for over a century, the structure of YFV has remained elusive. Here we use a chimeric virus platform to resolve the first high resolution cryo-EM structures of YFV. Stark differences in particle morphology and homogeneity are observed between vaccine and virulent strains of YFV, and these are found to have significant implications on antibody recognition and neutralisation. We identify a single residue (R380) in the YFV17D envelope protein that stabilises the virion surface, and leads to reduced exposure of the cross-reactive fusion loop epitope. The differences in virion morphology between YFV strains also contribute to the reduced sensitivity of the virulent YFV virions to vaccine-induced antibodies. These findings have significant implications for YFV biology, vaccinology and structure-based flavivirus antigen design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures